Recruiting OBSERVATIONAL NCT06629194
Validation of Scoring Systems for Differentiating Intestinal Tuberculosis from Crohn's Disease
Validation of Scoring Systems for Differentiating Intestinal Tuberculosis from Crohn's Disease Utilizing Clinical, Endoscopic, and Interferon-gamma Releasing Assay in Asian Population
Sponsor: Korean Association for the Study of Intestinal Diseases
Interventions
interferon gamma releasing assay (IGRA)
Updated 1 time since 2024 Last updated: Oct 4, 2024 Started: Jun 9, 2024 Primary completion: Dec 31, 2025 Completion: Mar 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Crohn Disease and Differential Diagnosis, this trial is actively recruiting participants. The trial is conducted by Korean Association for the Study of Intestinal Diseases and has accumulated 1 data snapshot since 2024. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Korean Association for the Study of Intestinal Diseases
- Mahidol University
Data source: Mahidol University
For direct contact, visit the study record on ClinicalTrials.gov .